[go: up one dir, main page]

ES541465A0 - Procedimiento para la produccion de una ciclosporina - Google Patents

Procedimiento para la produccion de una ciclosporina

Info

Publication number
ES541465A0
ES541465A0 ES541465A ES541465A ES541465A0 ES 541465 A0 ES541465 A0 ES 541465A0 ES 541465 A ES541465 A ES 541465A ES 541465 A ES541465 A ES 541465A ES 541465 A0 ES541465 A0 ES 541465A0
Authority
ES
Spain
Prior art keywords
cyclosporine
procedure
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541465A
Other languages
English (en)
Other versions
ES8702926A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES541465A0 publication Critical patent/ES541465A0/es
Publication of ES8702926A1 publication Critical patent/ES8702926A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES541465A 1984-03-23 1985-03-21 Procedimiento para la produccion de una ciclosporina Expired ES8702926A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (2)

Publication Number Publication Date
ES541465A0 true ES541465A0 (es) 1987-01-16
ES8702926A1 ES8702926A1 (es) 1987-01-16

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541465A Expired ES8702926A1 (es) 1984-03-23 1985-03-21 Procedimiento para la produccion de una ciclosporina

Country Status (24)

Country Link
US (1) US4639434A (es)
JP (1) JPH08838B2 (es)
AT (1) AT388737B (es)
BE (1) BE901980A (es)
CA (1) CA1247546A (es)
CH (1) CH667274A5 (es)
CS (1) CS249542B2 (es)
DE (1) DE3509809A1 (es)
DK (1) DK128285A (es)
ES (1) ES8702926A1 (es)
FI (1) FI851120A7 (es)
FR (1) FR2561651B1 (es)
GB (1) GB2155936B (es)
GR (1) GR850716B (es)
HU (1) HU200786B (es)
IL (1) IL74681A (es)
IT (1) IT1199962B (es)
LU (1) LU85819A1 (es)
NL (1) NL8500828A (es)
NO (1) NO851160L (es)
NZ (1) NZ211526A (es)
PH (2) PH23357A (es)
PT (1) PT80149B (es)
SE (1) SE461334B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587505T2 (de) 1984-10-04 1994-01-05 Sandoz Ag Monoklonale antikörper gegen zyklosporine.
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
DE3888357T2 (de) * 1987-06-22 1994-09-15 Merck & Co Inc Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
ATE109970T1 (de) * 1987-09-03 1994-09-15 Univ Georgia Res Found Cyclosporin-augenmittel.
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (es) * 1988-05-13 1991-12-31 Sandoz Ag
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
DK0484281T4 (da) 1990-11-02 2001-02-05 Novartis Ag Cyclosporiner
DE69121844T2 (de) 1990-11-20 1997-01-23 Behringwerke Ag Immunotest für Cyclosporin
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
RU2170741C2 (ru) * 1996-08-16 2001-07-20 Новартис Аг Способ получения циклоспорина
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
JP4261049B2 (ja) 1997-10-08 2009-04-30 アイソテクニカ インコーポレイテッド 重水素化シクロスポリンアナログおよび免疫調節剤としてのそれらの使用
US5990274A (en) * 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
MXPA04003623A (es) * 2001-10-19 2004-12-02 Isotechnika Inc Nuevas formulaciones analogas de ciclosporina.
ES2266564T3 (es) 2001-10-19 2007-03-01 Isotechnika Inc. Sintesis de analogos de cicloporinas.
WO2004082629A2 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
JP2008514701A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキン類似体およびそれらの薬学的使用
EP1804823A4 (en) * 2004-09-29 2010-06-09 Amr Technology Inc NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
US7361636B2 (en) * 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7576057B2 (en) 2006-11-20 2009-08-18 Scynexis, Inc. Cyclic peptides
PL2651965T3 (pl) 2010-12-15 2019-04-30 Contravir Pharmaceuticals Inc Cząsteczki analogów cyklosporyny modyfikowane w aminokwasach 1 i 3
FI3556774T3 (fi) 2011-03-11 2024-03-15 Beth Israel Deaconess Medical Ct Inc Anti-cd40-vasta-aineita ja niiden käyttötapoja
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
HUE056769T2 (hu) 2015-09-04 2022-03-28 Primatope Therapeutics Inc Humanizált anti-CD40 antitestek és felhasználásuk

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056782B1 (en) * 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine

Also Published As

Publication number Publication date
AT388737B (de) 1989-08-25
FR2561651A1 (fr) 1985-09-27
PH21868A (en) 1988-03-25
PH23357A (en) 1989-07-14
FI851120L (fi) 1985-09-24
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
US4639434A (en) 1987-01-27
JPS60215700A (ja) 1985-10-29
CH667274A5 (de) 1988-09-30
IL74681A (en) 1989-09-10
LU85819A1 (fr) 1985-12-12
PT80149B (en) 1987-03-23
GB2155936A (en) 1985-10-02
BE901980A (fr) 1985-09-23
SE8501392D0 (sv) 1985-03-21
GB2155936B (en) 1987-09-16
SE461334B (sv) 1990-02-05
FI851120A7 (fi) 1985-09-24
SE8501392L (sv) 1985-09-24
DK128285A (da) 1985-09-24
JPH08838B2 (ja) 1996-01-10
PT80149A (en) 1985-04-01
HU200786B (en) 1990-08-28
ES8702926A1 (es) 1987-01-16
NZ211526A (en) 1988-08-30
GR850716B (es) 1985-07-19
FR2561651B1 (fr) 1990-03-09
HUT38370A (en) 1986-05-28
FI851120A0 (fi) 1985-03-20
IT1199962B (it) 1989-01-05
GB8507270D0 (en) 1985-04-24
IL74681A0 (en) 1985-06-30
NO851160L (no) 1985-09-24
IT8547852A0 (it) 1985-03-22
NL8500828A (nl) 1985-10-16
CS249542B2 (en) 1987-03-12
IT8547852A1 (it) 1986-09-22
DE3509809A1 (de) 1986-01-09
DK128285D0 (da) 1985-03-21

Similar Documents

Publication Publication Date Title
ES541465A0 (es) Procedimiento para la produccion de una ciclosporina
ES556927A0 (es) Procedimiento para la produccion de derivados de la 13-betamilbemicina
DOP1990004769A (es) Proceso para la preparacion de una modificacion de cristales
ES547840A0 (es) Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas
ES544525A0 (es) Un procedimiento para la produccion de una solucion estabi- lizada de una isotiazolona
ES556313A0 (es) Procedimiento para la produccion de gamma-butirolactona.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES548220A0 (es) Un procedimiento para la produccion de un derivado de dia- midas de n-acilaminoacidos
ES536070A0 (es) Un procedimiento para la produccion de una cefalosporina
ES540732A0 (es) Un procedimiento para la polimeracion de una alfa-monoolefina.
ES540200A0 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
ES543999A0 (es) Un procedimiento para la produccion de dihidropiridinas
ES557112A0 (es) Procedimiento para la obtencion de una 9 l 11 l epoxiesteroide
ES546296A0 (es) Un procedimiento para la produccion de una cefalosporina
ES546497A0 (es) Procedimiento para la fabricacion de un cuerpo hueco hincha-ble
MX5857E (es) Procedimiento mejorado para la produccion de una enzima de fructosil transferasa
ES547205A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
ES545298A0 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
ES548939A0 (es) Un procedimiento para la produccion de dimetilamina
ES534677A0 (es) Procedimiento para la produccion de una cepa de agaricus bisporis
ES544640A0 (es) Un procedimiento para la preparacion de una cefalosporina
ES540590A0 (es) Un procedimiento para la produccion de enol-esteres de oxi- cams.
ES547777A0 (es) Un procedimiento para la produccion de elastomeros de poliu-retano-urea
ES542882A0 (es) Un procedimiento para la preparacion de nuevas sulfonilureas.
ES550351A0 (es) Procedimiento para la produccion de 8-alfa-acilamino-ergolinas.